MedTrace Logo

Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surgery

NCT03202472 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-07-24

Study results available
· View outcomes & findings →

Summary

This pilot clinical trial studies radiofrequency technology in locating non-palpable breast lesions in patients undergoing surgery. Placing a miniature radiofrequency tag or microchip in the breast lesion before surgery and using a handheld device to guide doctors during surgery may improve surgical outcomes in patients with non-palpable breast lesions.

Conditions

  • Breast Neoplasm
  • Lesion

Interventions

DEVICE

Implanted Medical Device

Radiofrequency tag

PROCEDURE

Mammography

Undergo mammogram for image-guided placement of radiofrequency tag

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Radiofrequency (RFID) -Guided Localization

Undergo radiofrequency-guided localization

PROCEDURE

Ultrasonography

Undergo ultrasound for image-guided placement of radiofrequency tag

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • Jonsson Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Maggie DiNome, MD · UCLA / Jonsson Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-03
Primary Completion
2018-01-12
Completion
2019-02-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03202472 on ClinicalTrials.gov